We are live on ! Find out more
NLVP

New Leaf Venture Partners Portfolio holdings

AUM $43M
1-Year Est. Return 25.55%
This Fund
S&P 500
This Quarter Est. Return
+7.32%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$390M
AUM Growth
-$40.1M
Cap. Flow
-$4.37M
Cap. Flow %
-1.12%
Top 10 Hldgs %
93.55%
Holding
19
New
1
Increased
–
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
ADXN
Addex Therapeutics
ADXN
+$508K

Top Sells

Rank Stock Value
1
ARVN icon
Arvinas
ARVN
+$4.88M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARVN icon
1
Arvinas
ARVN
$572M
$170M 43.73%
2,212,748
-70,300
-3% -$4.88M
CRNX icon
2
Crinetics Pharmaceuticals
CRNX
$8.92B
$44.3M 11.37%
141,000
– –
EWTX icon
3
Edgewise Therapeutics
EWTX
$4.68B
$43.8M 11.24%
1,553,661
– –
DCPH
4
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$33.1M 8.51%
1,209,571
– –
OBSV
5
DELISTED
ObsEva SA Ordinary Shares
OBSV
$33.1M 8.49%
900,501
– –
CMRX
6
DELISTED
Chimerix, Inc.
CMRX
$9.8M 2.51%
1,224,600
– –
APTX
7
DELISTED
Aptinyx Inc. Common Stock
APTX
$9.31M 2.39%
3,290,079
– –
PDSB icon
8
PDS Biotechnology
PDSB
$43.4M
$7.97M 2.05%
117,242
– –
ALEC icon
9
Alector
ALEC
$198M
$7.07M 1.82%
339,569
– –
ARAV
10
DELISTED
Aravive, Inc. Common Stock
ARAV
$5.66M 1.45%
946,423
– –
CHMA
11
DELISTED
Chiasma, Inc. Common Stock
CHMA
$5.37M 1.38%
1,135,700
– –
SRRA
12
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$4.07M 1.04%
409,611
– –
HARP
13
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$3.36M 0.86%
315,670
– –
TECX
14
Tectonic Therapeutic
TECX
$585M
$2.81M 0.72%
26,296
– –
ITRM
15
DELISTED
Iterum Therapeutics
ITRM
$2.73M 0.7%
97,087
– –
COGT icon
16
Cogent Biosciences
COGT
$7.24B
$2.66M 0.68%
501,530
– –
XFOR icon
17
X4 Pharmaceuticals
XFOR
$438M
$2.18M 0.56%
11,167
– –
PASG icon
18
Passage Bio
PASG
$14.1M
$1.47M 0.38%
124,896
– –
ADXN
19
Addex Therapeutics
ADXN
$7.34M
$478K 0.12%
+2,500
New +$508K

Similar funds

BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

New Leaf Venture Partners's Q2 2021 Portfolio in Review

As of Q2 2021, New Leaf Venture Partners held 19 positions worth $390M, down 9.3% from $430M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

New Leaf Venture Partners's Q2 2021 filing shows 1 new and 1 reduced positions. Its largest new stake was Addex Therapeutics: 2,500 shares worth $478K. The largest sale was Arvinas, an estimated $4.88M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • New Leaf Venture Partners's largest Q2 2021 buy was Addex Therapeutics: 2,500 shares worth $478K.
  • New Leaf Venture Partners's biggest Q2 2021 reduction was Arvinas, cutting an estimated $4.88M.
  • New Leaf Venture Partners's ten largest holdings make up 94% of its $390M portfolio in Q2 2021.
  • New Leaf Venture Partners opened 1 new position and closed 0 in Q2 2021.
  • New Leaf Venture Partners's portfolio value fell 9.3% quarter-over-quarter to $390M.

Based on New Leaf Venture Partners's 13F filing for Q2 2021, filed 12 Aug 2021.